Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $328.00. The company’s shares closed yesterday at $292.95. Amsellem covers the Healthcare sector, ...

Piper Sandler downgraded Best Buy Co (NYSE:BBY). to Neutral from Overweight and cut its price target to $75, warning that the U.S. electronics retailer is unlikely to deliver meaningful growth in the ...